These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8013881)

  • 1. A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa).
    Upton SJ; Tilley M; Nesterenko MV; Brillhart DB
    FEMS Microbiol Lett; 1994 May; 118(1-2):45-9. PubMed ID: 8013881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Cryptosporidium parvum development in various cell lines for screening in vitro drug testing.
    Siripanth C; Punpoowong B; Amarapal P; Thima N; Eampokalap B; Kaewkungwal J
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):540-6. PubMed ID: 15689063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of the hierarchy and synergism of the bile derived signal on Cryptosporidium parvum excystation and infectivity.
    King BJ; Keegan AR; Phillips R; Fanok S; Monis PT
    Parasitology; 2012 Oct; 139(12):1533-46. PubMed ID: 22894830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utilization of sodium taurocholate in excystation of Cryptosporidium parvum and infection of tissue culture.
    Gold D; Stein B; Tzipori S
    J Parasitol; 2001 Oct; 87(5):997-1000. PubMed ID: 11695421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical comparison of excystation methods in Cryptosporidium parvum oocysts.
    Pecková R; Stuart PD; Sak B; Květoňová D; Kváč M; Foitová I
    Vet Parasitol; 2016 Oct; 230():1-5. PubMed ID: 27884435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics analysis and protein expression during sporozoite excystation of Cryptosporidium parvum (Coccidia, Apicomplexa).
    Snelling WJ; Lin Q; Moore JE; Millar BC; Tosini F; Pozio E; Dooley JS; Lowery CJ
    Mol Cell Proteomics; 2007 Feb; 6(2):346-55. PubMed ID: 17124246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete development of Cryptosporidium parvum in MDBK cells.
    Villacorta I; de Graaf D; Charlier G; Peeters JE
    FEMS Microbiol Lett; 1996 Aug; 142(1):129-32. PubMed ID: 8759799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of in vitro evaluation of chemical disinfectants for efficacy on Cryptosporidium parvum oocysts.
    Delling C; Lendner M; Müller U; Daugschies A
    Vet Parasitol; 2017 Oct; 245():5-13. PubMed ID: 28969838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intact Cryptosporidium parvum oocysts isolated after in vitro excystation are infectious to neonatal mice.
    Neumann NF; Gyürék LL; Finch GR; Belosevic M
    FEMS Microbiol Lett; 2000 Feb; 183(2):331-6. PubMed ID: 10675606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of three common hospital liquid germicides to inactivate Cryptosporidium parvum oocysts.
    Wilson JA; Margolin AB
    J Hosp Infect; 1999 Jul; 42(3):231-7. PubMed ID: 10439996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes and viability of Cryptosporidium parvum sporozoites after excystation in cell-free culture media.
    Matsubayashi M; Ando H; Kimata I; Nakagawa H; Furuya M; Tani H; Sasai K
    Parasitology; 2010 Nov; 137(13):1861-6. PubMed ID: 20800015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical and physical factors affecting the excystation of Cryptosporidium parvum oocysts.
    Kato S; Jenkins MB; Ghiorse WC; Bowman DD
    J Parasitol; 2001 Jun; 87(3):575-81. PubMed ID: 11426720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorine dioxide inactivation of Cryptosporidium parvum oocysts and bacterial spore indicators.
    Chauret CP; Radziminski CZ; Lepuil M; Creason R; Andrews RC
    Appl Environ Microbiol; 2001 Jul; 67(7):2993-3001. PubMed ID: 11425712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoassay for viable Cryptosporidium parvum oocysts in turbid environmental water samples.
    Call JL; Arrowood M; Xie LT; Hancock K; Tsang VC
    J Parasitol; 2001 Feb; 87(1):203-10. PubMed ID: 11227892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture.
    Hijjawi NS; Meloni BP; Morgan UM; Thompson RC
    Int J Parasitol; 2001 Aug; 31(10):1048-55. PubMed ID: 11429168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic effect of human alpha-1-antitrypsin on excystation of Cryptosporidium parvum oocysts.
    Forney JR; Yang S; Healey MC
    J Parasitol; 1997 Aug; 83(4):771-4. PubMed ID: 9267429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphology and in vitro infectivity of sporozoites of Cryptosporidium parvum.
    Petry F; Kneib I; Harris JR
    J Parasitol; 2009 Oct; 95(5):1243-6. PubMed ID: 19492897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptosporidium parvum oocyst viability and behaviour of the residual body during the excystation process.
    Kar S; Daugschies A; Cakmak A; Yilmazer N; Dittmar K; Bangoura B
    Parasitol Res; 2011 Dec; 109(6):1719-23. PubMed ID: 21603913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptosporidium parvum development in the BS-C-1 cell line.
    Deng MQ; Cliver DO
    J Parasitol; 1998 Feb; 84(1):8-15. PubMed ID: 9488330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of Cryptosporidium oocysts to different excystation conditions.
    Widmer G; Klein P; Bonilla R
    Parasitology; 2007 Oct; 134(Pt 11):1583-8. PubMed ID: 17506930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.